# DESCRIPTION

## STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT

- disclose government rights

## BACKGROUND OF THE INVENTION

- describe RA and its effects
- discuss limitations of current treatments

## BRIEF SUMMARY OF THE INVENTION

- introduce LLP2A-bisphosphonate conjugate
- describe method for reducing arthritis pain
- describe method for reducing cartilage and bone destruction
- outline various embodiments of the invention

## DETAILED DESCRIPTION OF THE INVENTION

### I. Introduction

- introduce peptidomimetic ligand-bisphosphonate conjugates for treating inflammation

### II. Definitions

- define abbreviations and terms
- describe principles of chemical bonding
- define pharmaceutical excipients and carriers

### III. Compositions for Treating Inflammation and Inflammatory Diseases

- introduce LLP2A-bisphosphonate conjugates for treating inflammation
- describe bisphosphonate drugs and their use
- provide formula for LLP2A compounds conjugated to bisphosphonate drugs
- describe salts, hydrates, solvates, prodrug forms, isomers, and metabolites
- introduce mesenchymal stem cells for modulating immune response

### IV. Formulation and Administration

- describe pharmaceutical compositions
- list oral preparations
- detail parenteral preparations
- formulate pharmaceutical compositions
- select suitable pharmaceutical carrier
- describe liquid form preparations
- detail solid form preparations
- formulate slow release formulations
- describe topical administration
- describe delivery by inhalation
- describe parenteral administration
- discuss unit dosage form

### V. Methods of Treating Inflammation

- describe methods of treating inflammation using conjugates
- outline methods of promoting anti-inflammatory or immunomodulatory effects
- detail methods of reducing signs or symptoms of arthritis pain

### VI. Examples

- illustrate use of LLP2A-Ale in reducing inflammation and bone loss

